TIMP2 and acute kidney injury: In animal models, TIMP-2 expression in renal tissues is associated with severity of AKI in vivo, whereas TIMP-2 silencing improves CLP-induced pro-inflammatory cytokine release by inhibiting the NF-κB pathway, and TIMP-2 downregulation protects renal tissues against endotoxin-induced AKI.